CSF3 and neutropenia: For example, the American Society of Clinical Oncology recommends that patients who are undergoing certain chemotherapy regimens receive prophylactic treatment with granulocyte colony-stimulating factor, which stimulates neutrophil production to counteract neutropenia (62).